Table 6.
Temporal associations between occurrence of the most frequent clinical manifestations and positive PNC assay results
| Clinical manifestation | Occurrence of clinical manifestation | |||||
|---|---|---|---|---|---|---|
| Same time as positive PNC | After positive PNC | |||||
| OR | 95 % CI | p Value | OR | 95 % CI | p Value | |
| Glomerulonephritis | 1.48 | 0.95–2.31 | 0.080 | 1.41 | 0.80–2.50 | 0.233 |
| Arthritis | 0.72 | 0.39–1.34 | 0.303 | 0.36 | 0.16–0.82 | 0.015 |
| Mucocutaneous | 1.36 | 0.94–1.97 | 0.105 | 1.68 | 1.15–2.46 | 0.007 |
| Alopecia | 0.87 | 0.47–1.60 | 0.657 | 1.37 | 0.81–2.32 | 0.239 |
| Hematological features | 7.67 | 2.98–19.74 | <0.001 | 0.59 | 0.28–1.26 | 0.173 |
| SLEDAI-2K >0 | 1.27 | 0.86–1.88 | 0.222 | 1.24 | 0.83–1.85 | 0.288 |
OR odds ratio, CI confidence interval, PNC phagocytosis of necrotic cell material, SLEDAI-2K Systemic Lupus Erythematosus Disease Activity Index 2000